Bridgewater Associates’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,118
Closed -$238K 718
2024
Q4
$238K Sell
21,118
-51,380
-71% -$903K ﹤0.01% 660
2024
Q3
$2.05M Sell
72,498
-80,387
-53% -$2.07M 0.01% 504
2024
Q2
$2.92M Sell
152,885
-22,854
-13% -$584K 0.02% 462
2024
Q1
$5.76M Sell
175,739
-28,638
-14% -$914K 0.03% 358
2023
Q4
$6.75M Sell
204,377
-18,590
-8% -$526K 0.04% 321
2023
Q3
$6.07M Buy
222,967
+16,453
+8% +$457K 0.04% 323
2023
Q2
$6.26M Sell
206,514
-8,963
-4% -$290K 0.04% 262
2023
Q1
$6.99M Buy
215,477
+19,542
+10% +$618K 0.04% 250
2022
Q4
$5.5M Sell
195,935
-37,800
-16% -$1.08M 0.03% 343
2022
Q3
$8.4M Sell
233,735
-6,806
-3% -$240K 0.04% 282
2022
Q2
$7.39M Buy
240,541
+13,705
+6% +$399K 0.03% 395
2022
Q1
$7.33M Buy
226,836
+56,491
+33% +$1.48M 0.03% 369
2021
Q4
$4.71M Buy
170,345
+18,245
+12% +$523K 0.03% 311
2021
Q3
$4.71M Sell
152,100
-6,413
-4% -$154K 0.03% 295
2021
Q2
$3.35M Buy
+158,513
New +$3.17M 0.02% 407

Other funds holding EVH

Bridgewater Associates's EVH Position: Q1 2025 in Review

Bridgewater Associates sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 21,118 shares — an estimated $238K sold.

Bridgewater Associates first reported a position in EVH in Q2 2021 and held it in 15 quarters. The position peaked at $8.4M in Q3 2022. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Bridgewater Associates reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 21,118 Evolent Health shares in Q1 2025, an estimated $238K.
  • Bridgewater Associates first reported a position in Evolent Health in Q2 2021 and held it in 15 quarters.
  • Bridgewater Associates's Evolent Health position peaked at $8.4M in Q3 2022.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.